205 related articles for article (PubMed ID: 37771589)
21. Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic Microangiopathy.
Okamura H; Nakamae H; Shindo T; Ohtani K; Hidaka Y; Ohtsuka Y; Makuuchi Y; Kuno M; Takakuwa T; Harada N; Nishimoto M; Nakashima Y; Koh H; Hirose A; Nakamae M; Wakamiya N; Hino M; Inoue N
Front Immunol; 2021; 12():695037. PubMed ID: 34326846
[TBL] [Abstract][Full Text] [Related]
22. Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation in adult patients: Diagnosis, incidence, prophylaxis, and treatment.
Özkan HA; Özkan SG
Transfus Apher Sci; 2022 Feb; 61(1):103372. PubMed ID: 35101376
[TBL] [Abstract][Full Text] [Related]
23. Systematic Review of Signs and Symptoms Associated with Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy.
Dandoy CE; Tsong WH; Sarikonda K; McGarvey N; Perales MA
Transplant Cell Ther; 2023 Apr; 29(4):282.e1-282.e9. PubMed ID: 36592719
[TBL] [Abstract][Full Text] [Related]
24. Novel Ultrasonographic Scoring System of Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation.
Nishida M; Kahata K; Hayase E; Shigematsu A; Sato M; Kudo Y; Omotehara S; Iwai T; Sugita J; Shibuya H; Shimizu C; Teshima T
Biol Blood Marrow Transplant; 2018 Sep; 24(9):1896-1900. PubMed ID: 29803752
[TBL] [Abstract][Full Text] [Related]
25. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation.
Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ
Br J Haematol; 2017 Jul; 178(1):112-118. PubMed ID: 28444784
[TBL] [Abstract][Full Text] [Related]
26. Defibrotide for Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Prophylaxis in High-Risk Adult Patients: A Single-Center Experience Study.
Picod A; Bonnin A; Battipaglia G; Giannotti F; Ruggeri A; Brissot E; Malard F; Médiavilla C; Belhocine R; Vekhoff A; Gueye MS; Lapusan S; Adaeva R; Isnard F; Legrand O; Baylatry MT; Joly AC; Labopin M; Duléry R; Mohty M
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1471-1475. PubMed ID: 29477779
[TBL] [Abstract][Full Text] [Related]
27. Veno-occlusive disease in children and adolescents after hematopoietic stem cell transplantation: Did the Modified Seattle Criteria fit the characteristics of pediatric population?
Szmit Z; Gorczyńska E; Mielcarek-Siedziuk M; Ussowicz M; Owoc-Lempach J; Kałwak K
Adv Clin Exp Med; 2020 Mar; 29(3):339-344. PubMed ID: 32207590
[TBL] [Abstract][Full Text] [Related]
28. Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation.
Lewis C; Kim HT; Roeker LE; Cutler C; Koreth J; Nikiforow S; Armand P; Gootpu M; Romee R; Glotzbecker B; Nageshwar P; Antin JH; Alyea EP; Richardson P; Soiffer RJ; Ho VT
Biol Blood Marrow Transplant; 2020 Mar; 26(3):529-539. PubMed ID: 31678537
[TBL] [Abstract][Full Text] [Related]
29. Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy.
Jodele S; Licht C; Goebel J; Dixon BP; Zhang K; Sivakumaran TA; Davies SM; Pluthero FG; Lu L; Laskin BL
Blood; 2013 Sep; 122(12):2003-7. PubMed ID: 23814021
[TBL] [Abstract][Full Text] [Related]
30. Hepatic veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation for thalassemia major: incidence, management, and outcome.
Lai X; Liu L; Zhang Z; Shi L; Yang G; Wu M; Huang R; Liu R; Lai Y; Li Q
Bone Marrow Transplant; 2021 Jul; 56(7):1635-1641. PubMed ID: 33608657
[TBL] [Abstract][Full Text] [Related]
31. Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation.
Corbacioglu S; Richardson PG
Expert Rev Gastroenterol Hepatol; 2017 Oct; 11(10):885-898. PubMed ID: 28825848
[TBL] [Abstract][Full Text] [Related]
32. Defibrotide sodium for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome.
Richardson PG; Triplett BM; Ho VT; Chao N; Dignan FL; Maglio M; Mohty M
Expert Rev Clin Pharmacol; 2018 Feb; 11(2):113-124. PubMed ID: 29301447
[TBL] [Abstract][Full Text] [Related]
33. Heparanase polymorphisms: influence on incidence of hepatic sinusoidal obstruction syndrome in children undergoing allogeneic hematopoietic stem cell transplantation.
Seifert C; Wittig S; Arndt C; Gruhn B
J Cancer Res Clin Oncol; 2015 May; 141(5):877-85. PubMed ID: 25335953
[TBL] [Abstract][Full Text] [Related]
34. Incidence of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease and Treatment with Defibrotide in Allogeneic Transplantation: A Multicenter Australasian Registry Study.
Coutsouvelis J; Kirkpatrick CM; Dooley M; Spencer A; Kennedy G; Chau M; Huang G; Doocey R; Copeland TS; Do L; Bardy P; Kerridge I; Cole T; Fraser C; Perera T; Larsen SR; Mason K; O'Brien TA; Shaw PJ; Teague L; Butler A; Watson AM; Ramachandran S; Marsh J; Khan Z; Hamad N
Transplant Cell Ther; 2023 Jun; 29(6):383.e1-383.e10. PubMed ID: 36934993
[TBL] [Abstract][Full Text] [Related]
35. Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: A Review Based on Physiopathology.
Milone G; Bellofiore C; Leotta S; Milone GA; Cupri A; Duminuco A; Garibaldi B; Palumbo G
J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35160072
[TBL] [Abstract][Full Text] [Related]
36. Insulin-like growth factor-I predicts sinusoidal obstruction syndrome following pediatric hematopoietic stem cell transplantation.
Ebbesen M; Weischendorff S; Kielsen K; Kammersgaard M; Juul A; Müller KG
Bone Marrow Transplant; 2021 May; 56(5):1021-1030. PubMed ID: 33219341
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Biomarkers for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Myeloablative Allogeneic Hematopoietic Cell Transplantation: Results from the Blood and Marrow Transplant Clinical Trials Network 1202 Study.
Putta S; Young BA; Levine JE; Reshef R; Nakamura R; Strouse C; Perales MA; Howard A; Pine P; Shi J; Zhang P; Ho VT; Saber W
Transplant Cell Ther; 2023 Mar; 29(3):166.e1-166.e10. PubMed ID: 36574581
[TBL] [Abstract][Full Text] [Related]
38. Incidence of Anicteric Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome and Outcomes with Defibrotide following Hematopoietic Cell Transplantation in Adult and Pediatric Patients.
Corbacioglu S; Kernan NA; Pagliuca A; Ryan RJ; Tappe W; Richardson PG
Biol Blood Marrow Transplant; 2020 Jul; 26(7):1342-1349. PubMed ID: 32200121
[TBL] [Abstract][Full Text] [Related]
39. [Sinusoidal obstruction disease (SOS), previous hepatic venoocclusive disease (VOD)--still serious complication after hematopoietic stem cell transplantation].
Gozdzik J; Krasowska-Kwiecień A; Wedrychowicz A
Przegl Lek; 2008; 65(4):203-8. PubMed ID: 18724548
[TBL] [Abstract][Full Text] [Related]
40. Higher Cryopreserved CD34
Kato S; Konuma T; Monna-Oiwa M; Isobe M; Takahashi S; Nannya Y
Transplant Cell Ther; 2022 Nov; 28(11):779.e1-779.e9. PubMed ID: 35995391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
